Experts around the world are reviewing the current composition of vaccines against coronavirus, although it is still too early to determine whether it will be necessary to develop a new one against omicron variant, highlighted today an expert from the World Health Organization (WHO).
LOOK: World record: the United States registers more than a million cases of coronavirus in 24 hours
“We have the experience of the flu vaccine and we have created a working group in coordination with the pharmaceutical sector to determine if a specific vaccine against the new variant is necessary, but it is still too early”, highlighted at a press conference the epidemiologist of the WHO Abdi Mahamud.
- WHO says it is not certain that the omicron variant will fall in the world as soon as in South Africa
- Ómicron: Australia faces record numbers of coronavirus of almost 50,000 infections by new variant
- Austria declares that Johnson & Johnson vaccine health certificates are invalid
The expert added that the high transmissibility of omicron it will cause it to become the dominant variant in many parts of the world, posing a danger to those countries that still have large unvaccinated population groups.
Before thinking about booster vaccines (some countries are already considering a fourth dose) “it is necessary to guarantee access to vaccines in those overcrowded countries with lower-middle income levels,” he said.
Mutations of the virus “occur in unvaccinated people, therefore tackling this problem is an imperative need to stop this disease,” said Mahamud.
- The day that ‘El Chapo’ Guzmán left a city without roses to bury his son
- Mexico will require a visa from Venezuelans to prevent them from reaching the United States
- The murdered actress Tania Mendoza and her love for the Mexican drug lord Arturo Beltrán Leyva
- “My husband cut off my hands with an ax”
- Tania Mendoza, actress of “La mera reina del sur” is shot to death in Mexico